(Q52861330)

9 May 2018

title

Assessing the impact of complications on the costs of Type II diabetes. (English)

1 reference

9 May 2018

0 references

R Williams

1

1 reference

9 May 2018

L Van Gaal

series ordinal

2

1 reference

9 May 2018

C Lucioni

series ordinal

3

1 reference

9 May 2018

CODE-2 Advisory Board

series ordinal

4

1 reference

9 May 2018

publication date

12 June 2002

1 reference

9 May 2018

published in

Diabetologia

1 reference

9 May 2018

volume

45

1 reference

9 May 2018

issue

7

1 reference

9 May 2018

page(s)

S13-7

1 reference

9 May 2018

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Lowering the risk of visual impairment and blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Nephropathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Direct medical costs of complications resulting from type 2 diabetes in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Diabetes mortality: new light on an underestimated public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

The cost of diabetic foot problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

The cost of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

The costs of nephropathy in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-0859-9

10.1007/S00125-002-0859-9

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018